Genome-wide expression analysis in Down syndrome: insight into immunodeficiency

Area of Science:

• Genomics
• Immunology
• Human Genetics

Background:

• Down syndrome (DS) results from trisomy of Human chromosome 21 (Hsa21).
• DS is linked to immune dysfunction, affecting individuals from infancy through childhood.
• Understanding gene expression in DS is crucial for elucidating immune system abnormalities.

Purpose of the Study:

• To characterize genome-wide gene expression patterns in uncultured peripheral blood cells from individuals with Down syndrome.
• To compare gene expression profiles between neonate and child age groups in DS.
• To identify specific genes and molecular pathways associated with immune dysfunction in DS.

Main Methods:

• Human Exon microarray analysis was performed on peripheral blood cells from DS individuals and age-matched controls.
• Gene expression data were analyzed for dysregulated transcript clusters, focusing on those on Hsa21.
• Quantitative polymerase chain reaction (qPCR) was used to validate microarray findings.

Main Results:

• Significant gene expression changes were observed in DS individuals compared to controls.
• In neonates, 174 transcript clusters were dysregulated (8 on Hsa21); in children, 383 were dysregulated (56 on Hsa21).
• Functional analysis identified enriched KEGG pathways related to immune function, including leukocyte migration and B cell signaling, in both age groups.

Conclusions:

• Gene expression patterns in Down syndrome differ significantly between neonates and children.
• Dysregulated genes are enriched in pathways critical for immune responses, supporting a link to DS-associated immunodeficiency.
• The study identifies candidate genes and pathways for further investigation into immune dysfunction in Down syndrome.